Evofem Biosciences, Inc. Registration Rights Agreements
16 Contracts & Agreements
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 28, 2024 (Filed With SEC on October 28, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 2, 2024 (Filed With SEC on October 3, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Filed With SEC on September 25, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of August 9, 2024 (Filed With SEC on August 14, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of July 12, 2024 (Filed With SEC on July 23, 2024)
- Form of Registration Rights Agreement (Filed With SEC on October 3, 2023)
- Form of Registration Rights Agreement (Filed With SEC on August 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on July 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on April 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 24, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 14, 2023)
- Form of Registration Rights Agreement (Filed With SEC on February 23, 2023)
- Registration Rights Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)
- Form of Registration Rights Agreement (Filed With SEC on April 27, 2020)
- Registration Rights Agreement (Filed With SEC on April 11, 2019)
- Registration Rights Agreement, dated as of November 25, 2015, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
